1. Home
  2. EDIT vs FUNC Comparison

EDIT vs FUNC Comparison

Compare EDIT & FUNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDIT
  • FUNC
  • Stock Information
  • Founded
  • EDIT 2013
  • FUNC 1900
  • Country
  • EDIT United States
  • FUNC United States
  • Employees
  • EDIT N/A
  • FUNC N/A
  • Industry
  • EDIT Biotechnology: Biological Products (No Diagnostic Substances)
  • FUNC Major Banks
  • Sector
  • EDIT Health Care
  • FUNC Finance
  • Exchange
  • EDIT Nasdaq
  • FUNC Nasdaq
  • Market Cap
  • EDIT 241.9M
  • FUNC 222.2M
  • IPO Year
  • EDIT 2016
  • FUNC N/A
  • Fundamental
  • Price
  • EDIT $2.69
  • FUNC $36.77
  • Analyst Decision
  • EDIT Buy
  • FUNC
  • Analyst Count
  • EDIT 12
  • FUNC 0
  • Target Price
  • EDIT $5.40
  • FUNC N/A
  • AVG Volume (30 Days)
  • EDIT 1.3M
  • FUNC 18.9K
  • Earning Date
  • EDIT 11-03-2025
  • FUNC 10-20-2025
  • Dividend Yield
  • EDIT N/A
  • FUNC 2.39%
  • EPS Growth
  • EDIT N/A
  • FUNC 62.90
  • EPS
  • EDIT N/A
  • FUNC 3.65
  • Revenue
  • EDIT $38,901,000.00
  • FUNC $81,451,000.00
  • Revenue This Year
  • EDIT N/A
  • FUNC $16.22
  • Revenue Next Year
  • EDIT N/A
  • FUNC $6.20
  • P/E Ratio
  • EDIT N/A
  • FUNC $10.06
  • Revenue Growth
  • EDIT N/A
  • FUNC 16.98
  • 52 Week Low
  • EDIT $0.91
  • FUNC $24.66
  • 52 Week High
  • EDIT $4.12
  • FUNC $42.50
  • Technical
  • Relative Strength Index (RSI)
  • EDIT 51.07
  • FUNC 60.45
  • Support Level
  • EDIT $2.56
  • FUNC $36.24
  • Resistance Level
  • EDIT $2.84
  • FUNC $37.43
  • Average True Range (ATR)
  • EDIT 0.17
  • FUNC 0.78
  • MACD
  • EDIT 0.00
  • FUNC -0.12
  • Stochastic Oscillator
  • EDIT 58.82
  • FUNC 34.08

About EDIT Editas Medicine Inc.

Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company is engaged in developing and commercializing genome editing technology.

About FUNC First United Corporation

First United Corp is active in the financial services domain. The scope of its offering includes checking, savings, money market deposit accounts and certificates of deposit, business loans, personal loans, mortgage loans and lines of credit extended to both individuals and businesses. The bank also provides residential real estate construction loans to builders and individuals for single-family dwellings. The company's reportable operating segments include community banking and wealth management. The company generates the majority of its revenue from the Community Banking segment, which is engaged in delivering financial products and services, including various loan and deposit products, to consumer, business, and not-for-profit customers.

Share on Social Networks: